Cancer and chronic kidney disease, an approach to kidney cancer

Currently, nephrologists are treating an increasing number of oncological patients, and kidney cancer is not an exception. The interdisciplinary team is a fundamental pillar of comprehensive treatment, especially when the decision to initiate dialysis therapy must be made. Kidney cancer accounts for 2 to 3% of all cancers, its highest incidence is observed in Western countries, it is the most common solid renal lesion and represents up to 90% of malignant renal tumors, and is more common in men than women, and between 60 and 70 years of age. Like in other cancers, the cause is unknown; some factors closely related to its development are smoking, obesity, and high blood pressure. Unfortunately, as with most malignant neoplasms, kidney cancer progresses asymptomatically. Beyond the classic triad, does not generate surrogates that allow its identification, and diagnostic imaging becomes important. Currently, a wide variety of pharmacological agents are available for its treatment.